Cargando…
Antibodies in serum of convalescent patients following mild COVID‐19 do not always prevent virus‐receptor binding
Autores principales: | Gattinger, Pia, Borochova, Kristina, Dorofeeva, Yulia, Henning, Rainer, Kiss, Renata, Kratzer, Bernhard, Mühl, Bernhard, Perkmann, Thomas, Trapin, Doris, Trella, Martina, Ettel, Paul, Tulaeva, Inna, Pickl, Winfried F., Valenta, Rudolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984338/ https://www.ncbi.nlm.nih.gov/pubmed/32734595 http://dx.doi.org/10.1111/all.14523 |
Ejemplares similares
-
Omicron: A SARS‐CoV‐2 variant of real concern
por: Gattinger, Pia, et al.
Publicado: (2022) -
Immunological imprint of COVID‐19 on human peripheral blood leukocyte populations
por: Kratzer, Bernhard, et al.
Publicado: (2020) -
Combined assessment of S‐ and N‐specific IL‐2 and IL‐13 secretion and CD69 neo‐expression for discrimination of post–infection and post‐vaccination cellular SARS‐CoV‐2‐specific immune response
por: Kratzer, Bernhard, et al.
Publicado: (2022) -
Neutralization of SARS‐CoV‐2 requires antibodies against conformational receptor‐binding domain epitopes
por: Gattinger, Pia, et al.
Publicado: (2021) -
Vaccine based on folded RBD‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants
por: Gattinger, Pia, et al.
Publicado: (2022)